EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Mechanism of Tumour Communication: Malignant Extracellular Vesicles‐Induced Aggressiveness in Benign Cells and Melatonin‐Driven Reversal

Barbara Maria Frigieri iD, Guilherme Silva Bruno Barbosa iD, Adriana Alonso Novais iD, Caroline Patini de Rezende iD, Fausto Almeida iD, Vinicius Augusto Simão iD, Mari Cleide Sogayar iD, Luiz Gustavo de Almeida Chuffa iD, Russel J Reiter iD, Debora Aparecida Pires de Campos Zuccari iD

Journal of Cellular and Molecular Medicine · 2026-08 · 30 (15)

DOI: 10.1111/jcmm.71309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 11.08.2026. Verfasst von Barbara Maria Frigieri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Molecular Research Laboratory (CMRL), Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, Brazil. Hauptthemen laut MEDLINE: Melatonin, Extracellular Vesicles, Cell Communication, Breast Neoplasms. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desevolvimento Cientfico e Tecnologico (CNPQ).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs/EV) are key mediators of intercellular communication and influence proliferation, migration, and metabolic reprogramming. In breast cancer, EVs released by malignant cells carry bioactive molecules capable of altering the behaviour of surrounding cells. However, it remains uncertain whether these vesicles can directly induce a more aggressive phenotype in benign mammary cells. Melatonin, known for its oncostatic properties, regulates proliferation, metabolism, and signalling pathways associated with tumour progression and may modulate EV‐mediated intercellular communication. This study evaluated whether EVs derived from four breast cancer cell lines (MCF‐7, MDA‐MB‐231, MDA‐MB‐453 and HCC70), treated or not with melatonin, can modify the phenotype of benign MCF10A cells. EVs were isolated from conditioned media and co‐cultured with benign cells. Assays of proliferation, viability, colony formation, migration, lactate production and immunofluorescence were performed to assess EV‐mediated effects. EVs derived from malignant cells promoted a more aggressive phenotype in benign cells, as evidenced by increased proliferation, migration, and phenotypic remodelling. In contrast, EVs derived from melatonin‐treated malignant cells were associated with reduced lactate production and attenuation of pro‐tumoural features. Overall, these findings demonstrate that tumour‐derived EVs can induce aggressive traits in benign mammary cells and suggest that melatonin exposure in donor cells modulates EV‐mediated effects, attenuating their pro‐tumoural influence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninExtracellular VesiclesCell CommunicationBreast NeoplasmsHumansCell ProliferationCell MovementFemaleMDA-MB-231 CellsCell Line, TumorMCF-7 CellsCulture Media, Conditioned

Stichwörter der Autor:innen

breast cancerextracellular vesiclesmelatoninphenotypic remodellingtumour microenvironment

Substanzen

MelatoninCulture Media, Conditioned

Autor:innen und Institutionen

  • Cancer Molecular Research Laboratory (CMRL), Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, Brazil.
  • Institute of Biosciences, Letters and Exact Sciences IBILCE/, UNESP, São José do Rio Preto, Brazil.
  • Department of Immunology and Biochemistry, Ribeirão Preto Medical School-USP, Cidade Universitária, Ribeirão Preto, Brazil.
  • Department of Structural and Functional Biology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, Brazil.
  • Nucel Group for Cellular and Molecular Therapy, São Paulo Medical School-USP, São Paulo, Brazil.
  • Biochemistry Department, Chemistry Institute, University of São Paulo, São Paulo, Brazil.

ORCID-Profile: Barbara Maria Frigieri, Guilherme Silva Bruno Barbosa, Adriana Alonso Novais, Caroline Patini de Rezende, Fausto Almeida, Vinicius Augusto Simão, Mari Cleide Sogayar, Luiz Gustavo de Almeida Chuffa, Russel J Reiter, Debora Aparecida Pires de Campos Zuccari

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
  • Conselho Nacional de Desevolvimento Cientfico e Tecnologico (CNPQ)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Frigieri, B. M., Barbosa, G. S. B., Novais, A. A., de Rezende, C. P., Almeida, F., Simão, V. A., Sogayar, M. C., Chuffa, L. G. A., Reiter, R. J., & Zuccari, D. A. P. C. (2026). A Novel Mechanism of Tumour Communication: Malignant Extracellular Vesicles‐Induced Aggressiveness in Benign Cells and Melatonin‐Driven Reversal. Journal of Cellular and Molecular Medicine, 30(15). https://doi.org/10.1111/jcmm.71309

Vancouver

Frigieri BM, Barbosa GSB, Novais AA, de Rezende CP, Almeida F, Simão VA, et al. A Novel Mechanism of Tumour Communication: Malignant Extracellular Vesicles‐Induced Aggressiveness in Benign Cells and Melatonin‐Driven Reversal. Journal of Cellular and Molecular Medicine. 2026;30(15). doi:10.1111/jcmm.71309

BibTeX
@article{Frigieri2026,
  author = {Frigieri, Barbara Maria and Barbosa, Guilherme Silva Bruno and Novais, Adriana Alonso and de Rezende, Caroline Patini and Almeida, Fausto and Simão, Vinicius Augusto and Sogayar, Mari Cleide and Chuffa, Luiz Gustavo de Almeida and Reiter, Russel J and Zuccari, Debora Aparecida Pires de Campos},
  title = {A Novel Mechanism of Tumour Communication: Malignant Extracellular Vesicles‐Induced Aggressiveness in Benign Cells and Melatonin‐Driven Reversal},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {15},
  doi = {10.1111/jcmm.71309}
}
Kostenlos starten →